Results 221 to 230 of about 550,426 (284)

Autophagy-enabled protein degradation: Key to platelet activation and ANGII production in patients with type 2 diabetes mellitus. [PDF]

Heliyon
Wu Q, Yu S, Zang S, Peng K, Wang Z.
europepmc   +1 more source

A Novel Pathway of Platelet Activation in ACS Mediated by LL-37 Immunoglobulin G Autoantibody Immune Complexes. [PDF]

JACC Basic Transl Sci
Dimayuga PC, Chyu KY, Zhao X, Zhou J, Lio NWM, Chernomordik F, Berman D, Shah PK, Cercek B.   +8 more
europepmc   +1 more source

Lipophilic index of serum phospholipids in patients with type 2 diabetes and atherosclerotic cardiovascular disease: links with metabolic control, vascular inflammation and platelet activation. [PDF]

Cardiovasc Diabetol
Rostoff P, Drwiła-Stec D, Majda A, Stępień K, Nessler J, Gajos G.   +5 more
europepmc   +1 more source

Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis. [PDF]

Thromb J
AlOmar S, Mitchell JL, AlZahrani E.
europepmc   +1 more source

Jak2 V617F clonal hematopoiesis promotes arterial thrombosis via platelet activation and cross talk.

Blood
Liu W, Pircher J, Schuermans A, Ul Ain Q, Zhang Z, Honigberg MC, Yalcinkaya M, Nakao T, Pournamadri A, Xiao T, Hajebrahimi MA, Wasner L, Stegner D, Petzold T, Natarajan P, Massberg S, Tall AR, Schulz C, Wang N.   +18 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Platelet Activation and Atherothrombosis

New England Journal of Medicine, 2007
This review of the role of platelets in atherothrombosis illuminates the surprisingly numerous activities of these tiny, anucleate cells and stresses their participation in the inflammatory component of atherothrombosis. The information is presented in the context of the prevention of atherothrombosis by antiplatelet agents now in clinical use.
DAVI', Giovanni, PATRONO C.
openaire   +5 more sources

Platelet Activity in Washed Platelet Concentrates

Anesthesia & Analgesia, 2004
Life-threatening anaphylaxis or febrile nonhemolytic transfusion reactions after transfusion of platelet concentrates (PCs) is a serious clinical problem caused by the sensitizing of recipients to plasma components, such as immunoglobulin A, or by cytokines. There is a possible indication for washing of PCs in these thrombocytopenic patients.
Aristomenis K. Exadaktylos, Hartmut Radtke, Helge Schoenfeld, Ulrich R. Doepfmer, Manfred Muhm   +4 more
openaire   +2 more sources

Platelet Activation in Psoriasis

Thrombosis and Haemostasis, 1985
SummaryRecent epidemiological studies have suggested that psoriasis represents a risk factor for thrombotic vascular diseases. In order to evaluate the possible role of hemostatic changes in the development of thrombotic episodes in psoriasis, some parameters of the hemostatic “balance” were investigated in 22 male psoriatic patients and compared to ...
G.G. Nenci, M. Berrettini, Constantini, S. Grasselli, P. Parise   +4 more
openaire   +3 more sources